Contravisory Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Sell
2,955
-56
-2% -$57.2K 0.63% 41
2026
Q1
$2.77M Sell
3,011
-129
-4% -$131K 0.57% 40
2025
Q4
$3.37M Buy
3,140
+106
+3% +$101K 0.67% 40
2025
Q3
$2.31M Sell
3,034
-166
-5% -$124K 0.45% 40
2025
Q2
$2.49M Buy
3,200
+162
+5% +$126K 0.49% 40
2025
Q1
$2.51M Buy
3,038
+2,423
+394% +$2.02M 0.53% 40
2024
Q4
$475K Sell
615
-39
-6% -$32.3K 0.1% 147
2024
Q3
$579K Buy
654
+34
+5% +$30.6K 0.12% 112
2024
Q2
$561K Sell
620
-24
-4% -$19.2K 0.12% 106
2024
Q1
$501K Buy
+644
New +$458K 0.11% 125
2023
Q2
Sell
-23,642
Closed -$8.12M 343
2023
Q1
$8.12M Sell
23,642
-399
-2% -$135K 2.29% 8
2022
Q4
$8.8M Buy
24,041
+1,245
+5% +$441K 2.44% 6
2022
Q3
$7.37M Buy
22,796
+67
+0.3% +$21.2K 2.46% 4
2022
Q2
$7.37M Sell
22,729
-217
-0.9% -$65.1K 2.39% 6
2022
Q1
$6.57M Buy
+22,946
New +$5.91M 1.86% 19
2019
Q3
Sell
-548
Closed -$61K 294
2019
Q2
$61K Buy
+548
New +$64.5K 0.02% 215
2016
Q2
Sell
-25
Closed -$2K 222
2016
Q1
$2K Hold
25
﹤0.01% 164
2015
Q4
$2K Buy
+25
New +$2.08K ﹤0.01% 171
2015
Q2
Sell
-400
Closed -$29K 184
2015
Q1
$29K Buy
400
+200
+100% +$14.2K 0.01% 96
2014
Q4
$14K Buy
+200
New +$13.5K ﹤0.01% 111

Other funds holding LLY

Contravisory Investment Management's LLY Position: Q2 2026 in Review

Contravisory Investment Management reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $57.2K and leaving 2,955 shares worth $3.54M. The position accounts for 0.63% of the portfolio, ranked #41.

Contravisory Investment Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. The position peaked at $8.8M in Q4 2022. 1,800 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Contravisory Investment Management held 2,955 shares of Eli Lilly worth $3.54M as of Q2 2026.
  • Contravisory Investment Management sold 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
  • Eli Lilly made up 0.63% of Contravisory Investment Management's portfolio in Q2 2026, its #41 holding.
  • Contravisory Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
  • Contravisory Investment Management's Eli Lilly position peaked at $8.8M in Q4 2022.
  • 1,800 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.